Neuronetics (STIM) Net Equity Issued and Repurchased (2021 - 2025)
Neuronetics' (STIM) quarterly Net Equity Issued and Repurchased came in at -$13000.0 in Q4 2025, down 100.16% on a QoQ basis from $8.3 million in Q3 2025.
Neuronetics (STIM) Net Equity Issued and Repurchased (2021 - 2025) Analysis & Trends
Neuronetics (STIM) has 2 years of Net Equity Issued and Repurchased data on file, last reported at -$13000.0 in Q4 2025.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to -$13000.0 in Q4 2025; TTM through Dec 2025 was $29.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $8.3 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased for Q4 2025 stood at -$13000.0, down from $8.3 million in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for STIM reached as high as $81.0 million in Q1 2021 and fell as low as -$13000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 12.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuronetics | 130.83 Mn | 128.62 Mn | 16.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -13,000.00 |
| Dec 31, 2025 | -13,000.00 |
| Sep 30, 2025 | 8.30 Mn |
| Sep 30, 2025 | 8.30 Mn |
| Mar 31, 2025 | 20.70 Mn |
| Mar 31, 2025 | 20.70 Mn |
| Mar 31, 2021 | 80.97 Mn |
| Mar 31, 2021 | 80.97 Mn |